High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer
Authors
Keywords
-
Journal
PATHOLOGY INTERNATIONAL
Volume 68, Issue 12, Pages 685-693
Publisher
Wiley
Online
2018-12-05
DOI
10.1111/pin.12736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer
- (2018) Yuki Kiyozumi et al. ANNALS OF SURGERY
- Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis
- (2018) Xiao Zheng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
- (2018) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species
- (2018) Yuki Kitano et al. JOURNAL OF PATHOLOGY
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Cancer as a tissue: The significance of cancer-stromal interactions in the development, morphogenesis and progression of human upper digestive tract cancer
- (2018) Hiroshi Yokozaki et al. PATHOLOGY INTERNATIONAL
- Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
- (2018) Aurélie Durgeau et al. Frontiers in Immunology
- The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
- (2017) Lieve Brochez et al. EUROPEAN JOURNAL OF CANCER
- Oesophageal cancer
- (2017) Jesper Lagergren et al. LANCET
- Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
- (2017) Toshihiro Kudo et al. LANCET ONCOLOGY
- PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer
- (2017) Taisuke Yagi et al. ANNALS OF SURGERY
- Genetic progression of Barrett’s oesophagus to oesophageal adenocarcinoma
- (2016) Eleanor M Gregson et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma
- (2016) Koji Ohnishi et al. CANCER SCIENCE
- Lymph node - an organ for T-cell activation and pathogen defense
- (2016) Georg Gasteiger et al. IMMUNOLOGICAL REVIEWS
- Next-generation TCR sequencing - a tool to understand T-cell infiltration in human cancers
- (2016) Isabel Poschke et al. JOURNAL OF PATHOLOGY
- T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma
- (2016) Zengchao Chen et al. JOURNAL OF PATHOLOGY
- The development and maintenance of resident macrophages
- (2016) Elisa Gomez Perdiguero et al. NATURE IMMUNOLOGY
- Role of tumor-associated macrophages in human malignancies: friend or foe?
- (2016) Motohiro Takeya et al. PATHOLOGY INTERNATIONAL
- SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions
- (2016) F. Pucci et al. SCIENCE
- Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice
- (2015) Manabu Takamatsu et al. CANCER SCIENCE
- CD169+macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells
- (2015) Caroline A. Bernhard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma
- (2015) Y. Saito et al. Cancer Immunology Research
- Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan
- (2015) N. van Baren et al. Cancer Immunology Research
- CD169 mediates the capture of exosomes in spleen and lymph node
- (2013) S. C. Saunderson et al. BLOOD
- Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma
- (2013) Manabu Shigeoka et al. CANCER SCIENCE
- CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma
- (2013) Koji Ohnishi et al. CANCER SCIENCE
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival
- (2011) T. Tsuchikawa et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens
- (2010) Kenichi Asano et al. IMMUNITY
- Macrophage differentiation and function in health and disease
- (2008) Makoto Naito PATHOLOGY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started